[Source: EarthTimes] – ImmuneRegen® BioSciences, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), will present its current findings on Homspera®, the company’s immune system-enhancing preclinical drug candidate, at the 2009 BIO International Convention (BIO 2009) May 18-21 in Atlanta, Ga.
For more information click here.